Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Expensive Underperformer
1406.4000 31.40 (2.28%)
NSE May 05, 2025 15:31 PM
Volume: 830.0K
 

logo
Glenmark Pharmaceuticals Ltd.
10 Jul 2024
1406.40
2.28%
pdf
More from Glenmark Pharmaceuticals Ltd.
Recommended
IPOs This Week: Ather Energy and Four Other Listings, Plus New Public Issues
| 05 May 2025, 04:52PM
Market closes higher, Netweb Tech's Q4FY25 net profit grows 41.8% QoQ to Rs 43 crore
Trendlyne Marketwatch | 05 May 2025, 04:01PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
| 29 Jun 2020